Progesterone for smoking relapse prevention following delivery: A pilot, randomized, double-blind study
Forray A, Gilstad-Hayden K, Suppies C, Bogen D, Sofuoglu M, Yonkers KA. Progesterone for smoking relapse prevention following delivery: A pilot, randomized, double-blind study. Psychoneuroendocrinology 2017, 86: 96-103. PMID: 28926762, PMCID: PMC5659923, DOI: 10.1016/j.psyneuen.2017.09.012.Peer-Reviewed Original ResearchConceptsPre-pregnancy smokingSmoking levelsWeek 8Progesterone levelsPlacebo-controlled pilot trialDouble-blind studyOral micronized progesteroneSerious adverse eventsWeeks of gestationMain outcome measuresHalf of womenEndogenous progesterone levelsRelapse prevention strategiesCurrent pilot studyPreliminary findingsPostpartum smokersMicronized progesteronePlacebo groupProgesterone groupProgesterone replacementEligible womenSecondary outcomesAdverse eventsPoint prevalencePostpartum women